2018 Press Releases
AMCP CEO Statement on FDA’s Proposed Guidance That Would Reclassify Insulin as a Biologic
AMCP CEO Susan A. Cantrell, RPh, CAE, issued a statement on the Food and Drug Administration’s release today of proposed guidance that would reclassify insulin as a biologic, as well as other guidances on biosimilars:
JMCP Research Highlight: Discrepancies Between FDA-Required Labeling and Evidence that Payers Cite in Drug Coverage Policies
When making specialty drug coverage decisions, payers often consider information that goes beyond what’s contained in the Food and Drug Administration (FDA)-required labeling, according to a study in the current issue of the Journal for Managed Care & Specialty Pharmacy.
JMCP Adds Two Editors in Response to Growing Number of Article Submissions
The Journal of Managed Care & Specialty Pharmacy (JMCP) is pleased to announce the addition of two experienced managed care pharmacy experts to the JMCP editorial team. The move addresses recent growth of the publication, which has seen author submissions increase by 20% during the past two years compared with the prior two-year period.
Value-Based Agreements Should Start Small and Simple, Say Stakeholders at AMCP Partnership Forum on the Role of Integrated Delivery Networks in Pharmaceutical Value-Based Agreements
Health care stakeholders aiming to advance the concept of value-based care models should start with small, simple initiatives to help ease compliance and legal concerns, suggested attendees of a recent Academy of Managed Care Pharmacy (AMCP) Partnership Forum on establishing value-based agreements for pharmaceuticals in integrated delivery networks (IDNs).
AMCP Partnership Forum Builds Infrastructure and Methodologies to Utilize Patient Reported Outcomes
A multimodal approach is needed to engage individuals in sharing patient reported outcomes (PROs) that can be used to advance objectives in value-based care and drug development, according to attendees of the Academy of Managed Care Pharmacy’s (AMCP) Partnership Forum last week on “Building the Foundation for Patient Reported Outcomes: Infrastructure and Methodologies.”
Proper Use of Low-Dose Aspirin Can Prevent Cardiac Events and Lower Costs, But Use in Clinical Practice Lags: Journal of Managed Care & Specialty Pharmacy
Appropriate low-dose aspirin utilization for primary and secondary cardiovascular event prevention can result in improved patient outcomes with significant cost savings for U.S. payers.
AMCP Foundation's 8th Annual Research Symposium Discusses Health Care Trends, Disruptors and Opportunities
ORLANDO, Fla., Oct. 24, 2018 -- Misaligned incentives that drive overutilization of certain treatments, a realization that everyone can't have everything, and the need to address social determinants to improve patient health are among the health care trends revealed at the Academy of Managed Care Pharmacy (AMCP) Foundation's 8th Annual Research Symposium.
Academy of Managed Care Pharmacy Kicks Off AMCP Nexus 2018: Preparing for the Next Generation of Care
ORLANDO, Fla., Oct. 22, 2018 -- Nearly 2,500 managed care pharmacy professionals have gathered in central Florida for the Academy of Managed Care Pharmacy's (AMCP) Nexus 2018, with the theme of Preparing for the Next Generation of Care.
AMCP Foundation and Allergan Offered Summer Internships in Managed Care Pharmacy
The AMCP Foundation is delighted to announce that two student pharmacists recently completed a summer internship organized by the Foundation and supported by Allergan Plc.
AMCP Foundation and Genentech Offered Summer Internships in Managed Care Pharmacy
The AMCP Foundation is delighted to announce that two student pharmacists recently completed a summer internship organized by the Foundation and supported by Genentech, Inc.
AMCP Foundation and Pfizer Offered Summer Internships in Managed Care Pharmacy
The AMCP Foundation is delighted to announce that six student pharmacists from across the country recently completed summer internship programs organized by the Foundation and supported by Pfizer, Inc.
Evidence of ‘Nocebo’ Effect in Patients Taking Biosimilar Products is Unclear, According to Research in JMCP
There is insufficient evidence to conclude that a nocebo effect—an adverse effect or perceived lack of effectiveness that occurs when a patient has negative expectations about taking a medication—is a factor when patients and prescribers are aware of a switch from a reference biologic to a corresponding biosimilar product. However, higher discontinuation rates for the infliximab biosimilar did occur when the change from the reference product was known, according to new research.
AMCP Partnership Forum to Develop Consensus Roadmap for Managing Total Cost of Care by Integrating Medical and Pharmacy Data
Health information technology (IT) should be the foundation of all business and clinical operations and not a secondary byproduct. That was one conclusion reached by health care stakeholders at an AMCP event last week on finding ways to better integrate medical and pharmacy data.
JMCP Research Highlight: Opioid Prescribing in Georgia Medicaid Program: Potentially Inappropriate Practices are Increasing
Potentially inappropriate prescribing practices for opioids in the Georgia Medicaid program are common and increasing despite policies aimed at reducing utilization, concludes a new study in the September issue of JMCP.
AMCP Urges FDA to Issue Final Guidance on Biosimilar Interchangeability Standards and Provide Education on Substituting Interchangeable Products
To increase utilization of biosimilars, AMCP is urging the U.S. Food and Drug Administration (FDA) to issue final guidance on interchangeability standards and develop educational materials that underscore the ability of pharmacists to automatically substitute an interchangeable biologic for its reference product.
AMCP Partnership Forum Examines Non-Traditional Payment and Benefit Models for High-Cost Pharmaceuticals
Long-term annuity payments, reinsurance markets, performance-based payments, and milestone contracting were among the suggested models that health care payers should consider in light of the increasing number of high-cost medications coming to market each year.
Academy of Managed Care Pharmacy Foundation Adds Two New Members to Board of Trustees
The AMCP Foundation is pleased to announce the addition of Susan Shiff, PhD, MBA; and Mary C. Young, MHPA, CEBS, to the Foundation’s 11-member Board of Trustees.
AMCP Foundation’s 5K for the Future Run/Walk Raises $50,000-plus for Education and Research
More than 200 registrants, including ten teams and 60 participants for the “Sleep-In for Wellness” fundraiser, participated in the event.
AMCP Applauds FDA for Final Guidance on Payer and Manufacturer Communications to Improve Patient Access to Emerging Therapies
AMCP commends the U.S. Food and Drug Administration (FDA) for issuing final guidance that clarifies how manufacturers can communicate truthful and non-misleading information with payers across a product’s lifecycle.
AMCP Foundation and Pharmerit Collect Record Number of Socks to Benefit Boston Residents
The Academy of Managed Care Pharmacy (AMCP) Foundation is delighted to announce that it collected 1,118 pairs of brand-new socks last month for individuals in need throughout the Boston area. In its fourth iteration, the sock drive was more successful than ever, doubling the number of pairs received at prior AMCP conferences.
AMCP Appoints Cynthia Reilly as Senior Vice President
AMCP is delighted to announce the appointment of Cynthia Reilly, MS, BS Pharm, as Senior Vice President. Ms. Reilly will work closely with the executive leadership team to implement AMCP’s new strategic plan, bringing more than 20 years of nonprofit and pharmacy leadership experience to the organization.
AMCP CEO Susan A. Cantrell, RPh, CAE, to Participate in ISPOR 2018 Conference Session on Value-Assessments and Drug Coverage Decisions
Susan A. Cantrell, RPh, CAE, will represent the payers’ perspective in a panel discussion on the use of value assessments in drug coverage decisions at the upcoming ISPOR 2018 Conference, May 19-23, in Baltimore.
AMCP CEO Susan A. Cantrell, RPh, CAE, Responds to President Trump’s Speech on Lowering Drug Costs
CEO Susan A. Cantrell, issued the following statement in response to President Trump’s speech today on lowering drug costs.
AMCP Foundation Announces Recipients of 2018 Best Poster Contests
The Academy of Managed Care Pharmacy (AMCP) Foundation is delighted to announce winners of its 2018 Best Poster Contests.
AMCP Foundation Announces Recipients of 2018 National P&T Competition
The Academy of Managed Care Pharmacy (AMCP) Foundation is pleased to announce winners of its 18th Annual National Student Pharmacist Pharmacy & Therapeutics (P&T) Competition.
Managed Care Pharmacy Leaders Are Honored at the Academy of Managed Care Pharmacy/AMCP Foundation Awards Dinner BOSTON, April 26, 2018 — The Academy of Managed Care Pharmacy and AMCP Foundation last night recognized a group of leaders who have contributed significantly to the profession of managed care pharmacy.
Thousands of Managed Care Pharmacists and Health Care Stakeholders Gather in Boston for AMCP Annual Meeting
BOSTON, April 24, 2018 — The Annual Meeting, which kicked off April 23 with pre-meeting events and runs through April 26, is the premier event for pharmacists, physicians, nurses and other health care professionals who manage pharmacy benefits for more than 270 million Americans.
AMCP Launches New Addiction Advisory Group (AAG) to Address Opioid Crisis Through Promotion of Best Practices, Innovative Care Models and Benefit Designs
The Addiction Advisory Group (AAG) will continue AMCP’s ongoing efforts to promote best practices that improve addiction prevention and treatment services.
AMCP Volunteers, Staff Advocate for Managed Care Pharmacy Issues at Annual Legislative Days Event
Teams of AMCP volunteer leaders and staff will visit more than 50 House and Senate offices to advocate on two crucial issues affecting managed care pharmacy.
AMCP CEO Susan A. Cantrell, RPh, CAE Issues Statement on White House 2019 Budget Proposal
The proposal, released today, considers many pharmacy-related issues, including opioid management, Medicaid, Medicare Part B, the 340B program and the Food and Drug Administration.
Cate Lockhart Appointed Program Director of Biologics and Biosimilars Collective Intelligence Consortium (BBCIC)
The Biologics and Biosimilars Collective Intelligence Consortium is pleased to announce that Cate Lockhart, PharmD, PhD, has been appointed BBCIC Program Director.
AMCP Praises the House E&C Subcommittee on Health for Advancing H.R. 2026 ‘Pharmaceutical Information Exchange (PIE) Act of 2017’
H.R. 2026 now goes to the full Energy and Commerce Committee for consideration.
Academy of Managed Care Pharmacy Announces New President-Elect, Three Board Members
AMCP is pleased to announce the recent election of four members to the AMCP Board of Directors for the 2018-2020 term. The Board will be sworn in at the AMCP Managed Care & Specialty Pharmacy Annual Meeting 2018, April 23-26 in Boston.